# Tateyama Kasei Company Ltd. – FDA Inspection, Jul 5, 2017

Source: https://www.keypedia.com/records/fda_inspections/tateyama-kasei-company-ltd/7483b02b-0657-44c6-8eb6-ae5a5cdbb1fc
Source feed: FDA_Inspections

> FDA inspection 1017463 of Tateyama Kasei Company Ltd., July 05, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 11. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017463
- Company Name: Tateyama Kasei Company Ltd.
- Inspection Date: 2017-07-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1236028 - 2024-03-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/tateyama-kasei-company-ltd/2b94956d-709f-471c-b280-76550c65b17a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c